ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,021.63
0.57%
US Tech 100
20,355.20
0.45%
다우존스 지수
44,860.31
0.28%
Bitcoin
92,838.20
0.94%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Amneal Pharmaceuticals Holding Co (AMRX)

  7. Amneal Pharmaceuticals Holding Co (AMRX) 뉴스

AMRX

Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Holding Co
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:AMRX
일자시간출처헤드라인심볼기업
2024/09/0605:05Business WireAmneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administrationNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/08/2100:26Business WireAmneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose VialsNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/08/2021:00Business WireAmneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose VialsNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/08/1504:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/08/1500:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/08/1418:56IH Market NewsUBS Beats Earnings Forecasts, Intel Divests Arm Holdings, Flutter Surges 9% in Premarket Trading, and MoreNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/08/0919:05Business WireAmneal Reports Second Quarter 2024 Financial ResultsNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/08/0805:45Business WireAmneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release CapsulesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/07/3005:05Business WireAmneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV BagsNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/07/1205:05Business WireAmneal to Report Second Quarter 2024 Results on August 9, 2024NYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/07/1005:05Business WireAmneal Launches FOCINVEZ™, the First Ready-to-Use Version of FosaprepitantNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/07/0121:00Business WireKashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)NYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/07/0121:00Business WireAmneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab BiosimilarNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/06/2821:00Business WireAmneal Releases 2023 Environmental, Social and Governance ReportNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/06/0521:00Business WireAmneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New TherapiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/2305:05Business WireAmneal to Participate at Upcoming Investor ConferenceNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/2305:05Business WireAmneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of CaliforniaNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/1704:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/1704:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/1505:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/1505:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/1505:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/1505:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/0805:18Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/0706:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/0706:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/0706:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/0706:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/0706:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
2024/05/0319:14Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
 검색 관련기사 보기:NYSE:AMRX

최근 히스토리

USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
COIN
ETHUSD
Ethereum
FX
USDJPY
US Dollar vs Yen
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
SPI
SP500
S&P 500
NYSE
NKE
Nike
NYSE
KO
Coca Cola
NYSE
BAC
Bank of America
COIN
SOLUSD
Solana
AMEX
XLF
Financial Select Sector
NASDAQ
GOOGL
Alphabet
FX
USDGBP
US Dollar vs Sterling
FX
USDEUR
US Dollar vs Euro
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유